Trials / Completed
CompletedNCT04445051
Investigation of New Intermittent Catheters in Healthy Volunteers
Exploratory Investigation on Performance and Safety of New Intermittent Catheters in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Coloplast A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Investigation of non-CE marked intermittent catheters. The study was a randomized, single blinded, cross-over investigation comparing two new catheters with a comparator catheter in 30 adult healthy volunteers.
Detailed description
The CP322 study investigated a novel non-CE marked intermittent catheter for males and females, designed in two different variants, Variant 1 and Variant 2, respectively. The study was conducted in Denmark and was a randomized, single blinded, cross-over investigation comparing the two new variant catheters with a comparator catheter in 30 adult healthy volunteers. For each participant, the study thus contained three test visits/treatment arms (Comparator, Variant 1 and Variant 2, respectively), to which the 30 participants were randomized using a randomization sequence of six (i.e., there were six different random options for the order in which the participants tested the three catheters). There were 4-14 days between the test visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SpeediCath® Standard male or female | Intermittent catheterization through the urethra draining the bladder, using SpeediCath® Standard male or female. |
| DEVICE | New intermittent Variant 1 catheter for male or female | Intermittent catheterization through the urethra draining the bladder, using the new Variant 1 for male or female. |
| DEVICE | New intermittent Variant 2 catheter for male or female | Intermittent catheterization through the urethra draining the bladder, using the new Variant 2 for male or female. |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2020-06-24
- Last updated
- 2023-07-03
- Results posted
- 2023-07-03
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04445051. Inclusion in this directory is not an endorsement.